Quick Takeaways
- Robert Redfield has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $291,632.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Robert Redfield
- Location
- Newtown, PA
- Summary
- The estimated net worth of Robert Redfield is at least $291,632 dollars as of 10 Mar 2026. Robert Redfield is the Chief Medical Officer of Traws Pharma, Inc. and owns shares of Traws Pharma, Inc. (TRAW) stock worth about $291.6K.
- Signature
- /s/ Robert Redfield
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Robert Redfield and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Traws Pharma, Inc. ($291,632).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Robert Redfield
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | Chief Medical Officer | $291,632 | 08 Mar 2026 |
Insider Transactions Reported by Robert Redfield:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.